UNLIMITED TURBO SHORT - NOVARTIS N Share Price

Certificat

F2NMB

NLBNPNL2JCJ8

Market Closed - Euronext Paris 06:32:45 27/05/2024 pm IST
1.512 EUR -1.43% Intraday chart for UNLIMITED TURBO SHORT - NOVARTIS N
Current month-17.42%
1 month-15.81%
Date Price Change
27/24/27 1.512 -1.43%
24/24/24 1.534 +6.01%
23/24/23 1.447 +4.55%
22/24/22 1.384 +4.14%
21/24/21 1.329 -4.59%

Real-time Euronext Paris

Last update May 27, 2024 at 06:32 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying NOVARTIS AG
IssuerLogo Issuer BNP Paribas BNP Paribas
F2NMB
ISINNLBNPNL2JCJ8
Date issued 13/10/2023
Strike 106.2 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 2.33
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.012
Lowest since issue 1.313

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
100.7 USD
Average target price
108.2 USD
Spread / Average Target
+7.44%
Consensus
  1. Stock Market
  2. Certificates
  3. F2NMB Certificat